SyntekaBio largest shareholder Jongseon Jeong increases stake by 0.07% via related party open market purchases, now holds 16.64%
This report is a routine change disclosure of shareholding by largest shareholder Jongseon Jeong and 10 related parties.
The key change is a related party Jeong Hwaseong's open market purchase of 16,764 shares, increasing total holdings to 4,037,365 shares with a 16.64% stake, a slight rise.
The filer holds the stake for management influence purposes as the largest shareholder, with no specific plans for control changes currently.
A pre-existing share pledge agreement covering 2,800,000 shares remains in place, with a loan amount of 2.85 billion KRW and an annual interest rate of 12%.
[AI Summary]This filing reflects a minor increase in the largest shareholder's stake and is a routine disclosure without new capital raising or control changes, thus limited direct impact on stock price. However, the existing large-scale pledge with high interest rate could pose a potential risk if additional funding needs arise.